Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1999 1
2007 1
2008 1
2009 1
2012 1
2013 1
2014 2
2015 1
2016 4
2017 2
2018 1
2019 1
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
Mosely SI, Prime JE, Sainson RC, Koopmann JO, Wang DY, Greenawalt DM, Ahdesmaki MJ, Leyland R, Mullins S, Pacelli L, Marcus D, Anderton J, Watkins A, Coates Ulrichsen J, Brohawn P, Higgs BW, McCourt M, Jones H, Harper JA, Morrow M, Valge-Archer V, Stewart R, Dovedi SJ, Wilkinson RW. Mosely SI, et al. Among authors: leyland r. Cancer Immunol Res. 2017 Jan;5(1):29-41. doi: 10.1158/2326-6066.CIR-16-0114. Epub 2016 Dec 6. Cancer Immunol Res. 2017. PMID: 27923825 Free article.
Epigenomic Modifications Mediating Antibody Maturation.
Sheppard EC, Morrish RB, Dillon MJ, Leyland R, Chahwan R. Sheppard EC, et al. Among authors: leyland r. Front Immunol. 2018 Feb 26;9:355. doi: 10.3389/fimmu.2018.00355. eCollection 2018. Front Immunol. 2018. PMID: 29535729 Free PMC article. Review.
Structured reflection on shared decision making.
Leyland R, Heath M, Neve H, Maynard V. Leyland R, et al. Clin Teach. 2021 Feb;18(1):55-61. doi: 10.1111/tct.13233. Epub 2020 Aug 20. Clin Teach. 2021. PMID: 32815256
miR-155: an ancient regulator of the immune system.
Vigorito E, Kohlhaas S, Lu D, Leyland R. Vigorito E, et al. Among authors: leyland r. Immunol Rev. 2013 May;253(1):146-57. doi: 10.1111/imr.12057. Immunol Rev. 2013. PMID: 23550644 Review.
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.
Williams GS, Mistry B, Guillard S, Ulrichsen JC, Sandercock AM, Wang J, González-Muñoz A, Parmentier J, Black C, Soden J, Freeth J, Jovanović J, Leyland R, Al-Lamki RS, Leishman AJ, Rust SJ, Stewart R, Jermutus L, Bradley JR, Bedian V, Valge-Archer V, Minter R, Wilkinson RW. Williams GS, et al. Among authors: leyland r. Oncotarget. 2016 Oct 18;7(42):68278-68291. doi: 10.18632/oncotarget.11943. Oncotarget. 2016. PMID: 27626702 Free PMC article.
The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation.
Lu D, Nakagawa R, Lazzaro S, Staudacher P, Abreu-Goodger C, Henley T, Boiani S, Leyland R, Galloway A, Andrews S, Butcher G, Nutt SL, Turner M, Vigorito E. Lu D, et al. Among authors: leyland r. J Exp Med. 2014 Oct 20;211(11):2183-98. doi: 10.1084/jem.20140338. Epub 2014 Oct 6. J Exp Med. 2014. PMID: 25288398 Free PMC article.
Multicentre study of investigation and management of inpatient hyponatraemia in the UK.
Tzoulis P, Evans R, Falinska A, Barnard M, Tan T, Woolman E, Leyland R, Martin N, Edwards R, Scott R, Gurazada K, Parsons M, Nair D, Khoo B, Bouloux PM. Tzoulis P, et al. Among authors: leyland r. Postgrad Med J. 2014 Dec;90(1070):694-8. doi: 10.1136/postgradmedj-2014-132885. Epub 2014 Nov 14. Postgrad Med J. 2014. PMID: 25398584 Free PMC article.
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page